Authors: MORTON AR TOFFELMIRE EB

Citation: Ar. Morton et Eb. Toffelmire, PHARMACOKINETICS AND PHARMACODYNAMICS OF PAMIDRONATE DISODIUM IN HEMODIALYSIS, Journal of the American Society of Nephrology, 8, 1997, pp. 2632-2632

Authors: MORTON AR MEERS C SINGER MA TOFFELMIRE EB HOPMAN W MCCOMB J MACKENZIE TA

Citation: Ar. Morton et al., QUANTITY OF DIALYSIS - QUALITY-OF-LIFE - WHAT IS THE RELATIONSHIP, ASAIO journal, 42(5), 1996, pp. 713-717

Authors: RALPH B TOFFELMIRE EB

Citation: B. Ralph et Eb. Toffelmire, ADVERSE-EFFECTS OF FERROUS GLUCONATE PRESCRIBED IN SPLIT DOSES COMPARED TO A SINGLE BEDTIME DOSE IN HEMODIALYSIS-PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 219-219

Authors: IQBAL S HOLLAND D TOFFELMIRE EB

Citation: S. Iqbal et al., DILTIAZEM INHIBITION OF CYCLOSPORINE METABOLISM PROVIDES COST-EFFECTIVE THERAPY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 219-219

Authors: BENOWITZ NL TOFFELMIRE EB

Citation: Nl. Benowitz et Eb. Toffelmire, THE USE OF HEMODIALYSIS AND HEMOPERFUSION IN THE TREATMENT OF THEOPHYLLINE INTOXICATION, Seminars in dialysis, 6(4), 1993, pp. 243-252

Authors: MEERS C MORTON AR TOFFELMIRE EB

Citation: C. Meers et al., DIALYSIS ACCESS MORBIDITY WITH HIGH-EFFICIENCY DIALYSIS, Dialysis & transplantation, 22(6), 1993, pp. 324